Main menu

Richard Guerrant receives the 2014 Maxwell Finland Award for Scientific Achievement

“Richard Guerrant MD is recognized as one of the world’s leading experts in enteric infections... studying the long-term physical and cognitive effects associated with diarrhea burdens in early childhood."  - Citation by President Jimmy Carter. Dr. Guerrant pictured with ID Division Chief, Dr. William Petri.




Multiple Outcomes in WHIL Innovations

Angelina Maphula, Clinical Psychologist and Rebecca Scharf, Pediatrician with CGH collaborate on child development research at UVa. The interdisciplinary Water and Health in Limpopo Innovations post-doctoral fellowship supports dynamic collaborations among microbiologists, pediatricians, psychologists and medical anthropologists. Applications for the fellowship will be accepted through the end of August.

2014 Center for Global Health Scholars

Welcome back to the University of Virginia Center for Global Health Scholars. Read about their work on their blog!

Our Mission

The University of Virginia's Center for Global Health promotes health in resource-limited settings by fostering the commitment of students, faculty and partners from many disciplines to address the diseases of poverty.


Join Our Mailing List


News & Announcements

Center for Global Health Staff Update

We are pleased to announce that April Ballard has been promoted to Associate Director of Program Development effective June 16th. April has been with CGH for over 12 years as the International Programs Coordinator.


Center for Design and Health Fellowship Opportunity for UVa Faculty

The CDH is accepting applications for its 2014-2015 class of fellows.  For application information, please see  The Center for Design and Health's mission is to pursue cross-disciplinary research to advance the design and planning of patient-centered medical facilities and healthy buildings, neighborhoods, towns, and cities.

Promising New Antibiotic Defies Conventional Wisdom on Treating Superbug

A new antibiotic being developed at the University of Virginia School of Medicine to combat the dangerous C. difficile superbug also appears effective against a wide array of other pathogens, including the Helicobacter pylori bacterium, a new study suggests. With antibiotic resistance a growing concern – and an alarming shortage of new antibiotics in development – the drug is notable because it works in a way that prevents microbes from becoming resistant to it.